Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2007 by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting

Study NCT00262860 Information provided by National Cancer Institute (NCI)

First Received on December 6, 2005. Last Updated on November 20, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

Hodgkin Disease

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Gemcitabine

More general drug interventions related to this trial

Sponsors listed in this trial